Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-07

Clinical Trial Update: Zinc Supplementation in Type 2 Diabetics [Phase 2, Phase 3]

View source ↗

Summary

An update on the outcomes of zinc supplementation in people with Type 2 diabetes mellitus across Phase 2 and Phase 3 studies that have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc supplement (zinc)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 2, Phase 3 | Status: COMPLETED